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Abstract 
Background: Enhanced Recovery After Surgery (ERAS) is a multimodal 
pathway developed to overcome the deleterious effect of perioperative stress 
after major surgery. In colorectal surgery, ERAS pathways reduced 
perioperative morbidity, hospital stay and costs. Similar concept should be 
applied for liver surgery. This study presents the specific ERAS Society 
recommendations for liver surgery based on the best available evidence and 
on expert consensus.  
Methods: A systematic review was performed on ERAS for liver surgery by 
searching EMBASE and Medline. Five independent reviewers selected 
relevant articles. Quality of randomized trials was assessed according to the 
Jadad score and CONSORT statement. The level of evidence for each item 
was determined using the GRADE system. The Delphi method was used to 
validate the final recommendations. 
Results: A total of 157 full texts were screened.  Thirty-seven articles were 
included in the systematic review and 16 of the 23 standard ERAS items were 
studied specifically for liver surgery. Consensus was reached among experts 
after 3 rounds. Prophylactic nasogastric intubation and prophylactic 
abdominal drainage should be omitted. The use of postoperative oral 
laxatives and minimally invasive surgery results in a quicker bowel recovery 
and shorter hospital stay. Goal directed fluid therapy with maintenance of a 
low intraoperative central venous pressure induces faster recovery. Early oral 
intake and mobilization is recommended.  There is no evidence to prefer 
epidural to other types of analgesia.  
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Conclusions: The current ERAS recommendations were elaborated based 
on the best available evidence and endorsed by the Delphi method. 
Nevertheless, prospective studies need to confirm the clinical use of the 
suggested protocol.  
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Enhanced Recovery After Surgery (ERAS) is a multimodal pathway 
developed to improve recovery after major surgery. The ERAS strategy 
has been validated in colorectal surgery and is applied in other specialties 
including urology, thoracic, vascular, and orthopedic surgery [1-3]. In 
colorectal surgery, ERAS pathways allow significant reduction in 
postoperative complications, faster functional recovery, shorter hospital 
stays and reduced costs, even in elderly patients [4-6]. Patients within 
ERAS pathways mainly benefit from reduced medical complications while 
surgical morbidity remains generally unchanged [5].  
Liver surgery is a major and challenging procedure for both 
anesthesiologists and surgeons, and for the patient. Major morbidity 
ranges from 17% in benign to 27% in malignant disease, with a mortality 
risk of up to 5% [7]. In particular, pulmonary complications may reach 30% 
with increased risk of thromboembolic events of 5% [7-10]. In addition, 
about 50% of patients experience nausea and adverse digestive events 
[11]. Perioperative stress is increased during major liver surgery and all 
measures implemented to reduce the metabolic stress response could 
potentially reduce medical complications [5]. A recent meta-analysis 
demonstrated that enhanced recovery pathways for liver surgery was 
associated with a significant decrease in postoperative complications and 
length of hospital stay compared to standard care [12]. However, the 
majority of studies including ERAS protocols in liver surgery were 
performed in patients with normal liver parenchyma while data in cirrhotic 
and obstructive jaundiced patients remained scarce. Unfortunately, 
published protocols vary widely and actual application of the intended 
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protocol (compliance) was provided in one single study only [13]. 
Furthermore, hepatic and colorectal surgeries differ in terms of underlying 
disease, co-morbidities, metabolic stress response and organ-specific 
complications. It is currently unclear whether the ERAS elements validated 
for colorectal surgery can be extrapolated and applied for liver surgery.  
The present systematic review elaborates specific ERAS Society 
guidelines for enhanced recovery care after liver surgery by systematic 
review of the literature and expert consensus with the Delphi method.  
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Methods 
1.1 Literature search and data selection 
 
According to the PRISMA statements [14], Embase and Medline 
(through Pubmed) were searched systematically using the medical subject 
headings (MeSH) “Hepatectomy AND the 23 pre-, intra-, and postoperative 
validated ERAS items”. Only full text articles in English were analyzed. 
Eligible articles included meta-analyses, randomized controlled trials 
(RCTs) or prospective cohort studies with control group published between 
January 1997 (1st landmark published study on ERAS [15]) and 1st 
December 2015. Retrospective series were considered only if data of 
better quality could not be identified.   
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1.2  Inclusion and exclusion criteria 
This systematic review focused on non-obstructive jaundiced 
patients without cirrhosis. All types of hepatectomy according to the 
Brisbane classification were included [16]. Major hepatectomy was 
defined as resection of 3 or more Couinaud’s segments. Patients with 
choledocho-jejunostomy or vascular reconstruction were also included. 
All series including liver transplantation and patients with additional 
non-liver surgery (e.g. hepato-pancreaticoduodenectomy, colorectal 
associated resection) were excluded.  
1.3  Data extraction and quality assessment 
The first literature search was performed independently by 5 
authors (EM, MH, MS, CS, and JP) in January 2015. The terms of 
interest were first identified in the title, secondly in the abstract or 
medical subject headings. All studies of interest were screened with 
thorough full text reading. The quality of RCTs included was assessed 
using the Jadad-score (range 0-5) and the Consolidated Standards of 
Reporting Trials (CONSORT) statement checklist [17, 18]. According to 
the published ERAS recommendations for pancreaticoduodenectomy 
[19], the level of evidence for each item was determined using the 
Grading of Recommendations Assessment Development and 
Evaluation (GRADE) system, in which the level of evidence was 
classified as high, moderate, low or very low [20]. The research team 
(EM, MH, ND) made a final decision on inclusion of a study or not, and 
was responsible for drafting the first manuscript.  
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1.4 Items analyzed 
The classical 23 ERAS items validated for colorectal surgery 
were analyzed for liver surgery (Table 1). When only evidence in 
colorectal surgery was found for an item, it was searched for any 
evidence or rationale that this item should not be used in liver surgery. 
1.5 Modified Delphi method 
A 3-round web-based Delphi approach was used in this 
consensus process [21]. Surgical program directors, chairmen of liver 
surgery departments, academic surgeons and anesthesiologists with 
publications involving ERAS and/or liver surgery were identified using 
PubMed database. They were deemed as “experts”. To ensure the 
international standpoint to this consensus, we aimed to recruit a panel 
of experts from America, Asia and Europe. A recruitment letter in 
English was sent via e-mail providing a brief outline of the project and 
its objectives. If invited experts did not respond to the invitation within 2 
weeks, a reminder was sent out. Further experts were invited if no 
answer came in the next 2 weeks or the expert declined to participate 
in the study. A positive response to the recruitment letter served as 
informed consent. 
In all 3 rounds, the manuscript was distributed by email via a 
secured web-link. As previously validated, a modified Delphi process 
was used [22]. Each expert was asked to comment and edit 
anonymously the recommendations for each ERAS item using the text 
editor track change system. The research team served in the role of 
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facilitator, undertaking the synthesis between rounds. The process of 
synthesis included discussion among the research team, exploring all 
expert opinions, disagreements and suggestions for change, before 
synthesized recommendations were drafted for each subsequent 
round. Consensus was defined as agreement by > 75% of raters [23]. 
 
Results 
The electronic search yielded 1867 potential studies. The 
selection process according to PRISMA guidelines is displayed in 
Figure 1. 
Overall 10 RCTs, 3 prospective case series, 5 retrospective 
case control series, 16 meta-analyses, 2 systematic reviews, and one 
expert opinion study were included in the analysis. The overall quality 
of RCTs was high (Table 2); 9 RCTs had a Jadad score >3. Among the 
23 published ERAS items for colorectal surgery, 16 were studied 
specifically for liver surgery (perioperative oral nutrition, perioperative 
oral immunonutrition, treatment with carbohydrates, postoperative 
artificial nutrition, anti-thrombotic prophylaxis, antimicrobial prophylaxis 
and skin preparation, type of incision, no routine resection site 
drainage, minimally invasive approach, peri-operative steroid 
administration, postoperative glycaemic control, no prophylactic 
nasogastric intubation, prevention of delayed gastric emptying, 
laxatives use, multimodal analgesia, and stringent fluid management). 
Seven items were not studied in liver surgery patients and data were 
extrapolated from previous studies in colorectal surgery (preoperative 
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counseling, no preoperative fasting, early mobilization, audit, early oral 
nutrition, prevention of postoperative nausea and vomiting (PONV) and 
prevention of postoperative ileus). The summary and grading of 
recommendations with their respective level of evidence are depicted 
in Table 1 and the results of the liver specific studies used for the 
analysis summarized in Table 2 (and suppl. Table 1). 
Delphi process results 
Seven experts agreed to participate to this consensus after the 
first invitation (1 from America, 1 from Japan, 1 from Netherlands, 2 
from England, 1 from France, and 1 from Switzerland). After 3 rounds, 
all recommendations were agreed between the experts with a minimum 
of 75%. Tables 3 summarize the items with <75% agreement in round 
1 and 2.  
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ERAS Recommendations 
 
1. Preoperative counseling 
There are no studies evaluating the therapeutic effect of 
preoperative counseling and patient education before liver surgery. 
However, it is documented that patient decision aids such as printed 
documents and online information sources increase the involvement of 
patients in decision-making process and also increase the value of 
informed consent [24]. In addition, leaflets or multimedia information 
regarding the procedure and details of the patients’ postoperative tasks 
improve results of perioperative feeding, mobilization and respiratory 
physiotherapy thereby reducing complications after major abdominal 
surgery [1, 19]. 
 
Recommendation: Patients should receive routine dedicated 
preoperative counseling and education before liver surgery. 
Evidence level: moderate  
Grade: strong 
 
  
 14 
2. Perioperative nutrition 
Malnutrition is an important modifiable risk factor for adverse 
outcomes after major surgery. Routine nutritional screening should be 
mandatory for all patients undergoing major surgery [25-27]. Several 
screening tools are available and their usefulness in clinical practice is 
demonstrated. The Nutritional Risk Score (NRS), the Malnutrition 
Universal Screening Tool and the Subjective Global Assessment 
(SGA) deserve particular mention [25, 28]. According to the ESPEN 
guidelines, delaying surgery to allow for preoperative enteral nutrition 
(for at least 2 weeks) is recommended in patients with at least one of 
the following criteria: weight loss >10-15% within 6 months, BMI<18.5 
kg/m2, and serum albumin<30 g/l (with no evidence of hepatic or renal 
dysfunction) [25, 28]. Current recommendations suggest 5-7 days of 
oral supplements before surgery in patients at risk of malnutrition [25, 
28]. In severely undernourished patients who cannot be fed adequately 
orally or enterally, parenteral nutrition is recommended (Grade A) [29].  
Recommendation: Patients at risk (weight loss >10-15% within 6 
months, BMI<18.5 kg/m2, and serum albumin<30 g/l in the absence 
of liver or renal dysfunction) should receive oral nutritional 
supplements for seven days prior to surgery. For severely 
malnourished patients (>10% WL), surgery should be postponed for 
at least 2 weeks to improve nutritional status and allow patients to 
gain weight. 
Evidence level: high 
Grade of recommendation: strong 
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3.  Perioperative oral immunonutrition  
Immunonutrition (IN) contains ω-3 fatty acids, arginine, and 
nucleic acids. So far, the only randomized study on nutrition and liver 
resection included 26 patients only [30], and no meaningful difference 
was reported. The ongoing PROPILS trial is likely to deliver a definitive 
answer: 200 IN patients will be compared to 200 patients receiving 
isocaloric isonitrogenous nutrition for seven days before liver resection 
with overall complications as primary endpoint [31].  
Recommendation: There is limited evidence for the use of IN in 
liver surgery.  
Evidence level: low 
Grade of recommendation: weak 
 
4. Preoperative fasting and pre-operative carbohydrate load 
Preoperative fasting no more than 2 hours for liquids and 6 
hours for solid food has proven to be safe and is recommended for 
digestive surgery [32]. A recent systematic review included 17 
randomized trials with 1,445 surgical patients [33]. Patients receiving 
carbohydrates had less perioperative insulin resistance and fewer 
symptoms like malaise, hunger, thirst, nausea or anxiety. No difference 
in terms of complications was observed but one study demonstrated 
reduced hospital stay [33]. Carbohydrate loading is firmly established in 
colorectal guidelines [34, 35] and may be recommended in major liver 
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surgery, since some data in the literature support the deleterious effect 
of insulin resistance on liver regeneration [36]. 
Recommendation: Preoperative fasting does not need to 
exceed 6 hours for solids and 2 hours for liquids. Carbohydrate 
loading is recommended the evening before liver surgery and 2 
hours before induction of anesthesia. 
Evidence level: No preoperative fasting more than 6 hours: 
moderate; Carbohydrate loading: low 
Grade of recommendation: No preoperative fasting more than 
6 hours: strong; Carbohydrate loading: weak 
 
5. Oral bowel preparation 
Mechanical bowel preparation (MBP) may lead to fluid and 
electrolyte imbalances [37]. There are neither studies nor evidences 
about MBP before liver surgery. 
Recommendation: Oral MBP is not indicated before liver 
surgery. 
Evidence level: low 
Grade of recommendation: weak 
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6. Pre-anesthetic medication  
 
A recent Cochrane review on premedication for day case surgery in 
adults suggested that patients receiving oral anxiolytics showed 
impairment of psychomotor function 4 hours post operatively, which 
reduced the patient’s ability to mobilize, eat and drink [39]. This may also 
hold in patients with impaired liver function after resection and long-acting 
sedative premedication should be avoided. In selected cases, short acting 
anxiolytics may be administered, to facilitate regional anesthesia prior to 
general anesthesia induction.  
Recommendations:  Long acting anxiolytic drugs should be 
avoided. Short acting anxiolytics may be used to perform 
regional analgesia prior to the induction of anesthesia.  
Evidence level:  moderate 
Grade of recommendation:  strong 
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7. Anti-thrombotic prophylaxis 
 
Major hepatectomy in a normal liver parenchyma is an 
independent risk factor for postoperative PE [9]. In a large comparative 
cohort study (n=419), patients treated with postoperative thrombo-
prophylaxis beginning at day 1 after major hepatectomy had lower 
post-operative symptomatic venous thromboembolism (VTE) [42]. 
LMWH or unfragmented heparin treatment should be initiated 2-12 
hours before surgery and continued until patients are fully mobile [19]. 
Of note, possible interference with the use of epidural analgesia still 
needs to be assessed. The heparin should be administered 12 hours 
prior to insertion of epidural catheter. A Cochrane meta-analysis 
supports continued treatment for 4 weeks after hospital discharge 
particularly in oncologic patients [43]. In addition, the use of 
compressive stockings and intermittent pneumatic compression 
devices can further decrease this risk [35]. 
 
Recommendation: LMWH or unfragmented heparin reduces 
the risk of thromboembolic complications and should be started 
2-12 hours before surgery, particularly in major hepatectomy. 
Intermittent pneumatic compression stockings should be added 
to further decrease this risk. 
Evidence level: Use of heparin: moderate; Use of intermittent 
pneumatic compression devices: low 
Grade of recommendation: Use of heparin: strong; Use of 
intermittent pneumatic compression devices: weak 
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8. Peri-operative steroid administration 
According to a previous meta-analysis including 5 RCTs’ (n=379 
patients) comparing pre-operative steroid administration to placebo 
during liver resection, pre-operative steroid use was associated with a 
significant reduction in levels of bilirubin and interleukin 6 (IL-6) on 
postoperative day 1 [44]. In addition, steroid used was associated with 
a trend towards lower incidence of post-operative complications. A 
more recent meta-analysis by Li et al. showed contradictory results, 
with no impact on postoperative complications after liver resection [45]. 
Most studies used methylprednisolone at a dosage of 30mg/kg 30 
minutes to 2 hours prior to surgery. The use of steroids in diabetics has 
not been studied and since the glycaemic control is impaired after 
hepatectomy it is best avoided in this group until further studies are 
available. 
Recommendation: Steroids (methylprednisolone) may be used 
before hepatectomy in normal liver parenchyma, since it 
decreases liver injury and intraoperative stress, without 
increasing the risk of complications. Steroids should not be 
given in diabetic patients. 
Evidence level: moderate 
Grade of recommendation: weak 
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9. Antimicrobial prophylaxis and skin preparation 
Liver surgery is classified as clean-contaminated surgery due to 
bile duct transsection. There is no clear evidence for systematic use of 
antimicrobial prophylaxis in liver surgery [46-48]. In addition, there is no 
evidence on the benefit of long- or short-term antibiotic therapy in 
patients with previous bile duct drainage (PBD). Up to 70% of PBD 
patients have positive bile cultures (4% with MRSA) and are associated 
in up to 30% of cases with surgical site infection (SSI), but without 
increased mortality or postoperative hospital stay compared to patients 
with negative bile cultures [49]. 
Based on the Advisory Statement from the National Surgical 
Infection Prevention Project, antibiotics should be administered before 
skin incision less than one hour before surgery [50]. In a recent 
Cochrane meta-analysis including 7 RCTs’ (n=521 patients), no 
antimicrobial method (i.e. perioperative antibiotic therapy, pre- and 
probiotics through enteral feeding catheter) could improve outcomes 
after liver surgery [46]. Hirokawa et al. demonstrated that postoperative 
antibiotic therapy with flomoxef sodium (3rd generation Cephalosporin) 
every 12 hours for 3 days did not prevent postoperative infectious 
complications compared to single preoperative administration [47]. The 
administration of antibiotics for 2 or 5 days after hepatectomy without 
biliary reconstruction did not modify SSI and systemic infections [48].  
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Recommendation: Single dose intravenous antibiotics should 
be administered before skin incision and less than one hour 
before hepatectomy. Postoperative “prophylactic” antibiotics are 
not recommended. 
Evidence level: moderate 
Grade of recommendation: strong 
Regarding skin preparation, one single RCT (n=100 patients) 
assessed the efficacy of chlorhexidine-gluconate for pre-hepatectomy 
skin cleansing [51]. According to this study, SSI (primary outcome 
measure) were not different compared to control with saline solution 
only. On the other hand, a recently published large RCT (n=849 
patients) including abdominal (and liver surgery) and non-abdominal 
types of surgery demonstrated that preoperative cleansing with 
chlorhexidine-alcohol 2% was superior to povidone-iodine to prevent 
SSI [52].  
Recommendation: Skin preparation with chlorhexidine 2% is 
superior to povidone-iodine solution.  
Evidence level: moderate 
Grade of recommendation: strong 
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10. Incision 
There are 4 major types of incision: median incision, right 
transverse incision with vertical extension to the xiphoid (J-shaped), 
subcostal incision extending to the left, and bilateral transverse incision 
with vertical extension (Mercedes-type). According to the two largest 
retrospective cohort studies (n=1426 and 626 patients, respectively) 
including one or multiple control groups, Mercedes-type incision had 
the highest incisional hernia risk at one year [53, 54]. Of note, 
perioperative morbidity and pulmonary complications were similar 
whatever the shape of the incision. For a better exposure of the 
hepatocaval junction, the inverted “L incision” (modified Makuuchi) can 
also be used [55]. 
Recommendation: The choice of incision is at the surgeon’s 
discretion. It depends on the patient’s abdominal shape and 
location in the liver of the lesion to be resected. Mercedes-type 
incision should be avoided due to higher incisional hernia risk. 
Evidence level: moderate 
Grade of recommendation: strong 
 
11. Minimally invasive approach 
 
The Second International Consensus Conference on 
Laparoscopic Liver Resections in Morioka 2014 (Japan) concluded that 
minor laparoscopic liver resections (LLRs) had become standard 
practice while major still remain innovative procedures and deserved 
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further investigations [56]. One single retrospective study assessed 
LLRs in patients within ERAS protocol and suggested its feasibility with 
acceptable risk and possible additional accelerate recovery with 
reduced length of stay [57]. The results of the on-going multicenter 
Orange-II trials assessing open versus laparoscopic left lateral hepatic 
sectionectomy within an enhanced recovery ERAS program may 
provide further evidence [58]. Twelve other systematic reviews were 
identified [59-70], 9 included meta-analysis comparing open versus 
laparoscopic liver surgery [61-63, 65-70]. These meta-analyses 
concluded that LLR was associated with lower intraoperative blood 
loss, blood transfusion, postoperative complications, and shorter 
hospital stay. In addition, LLR reduced the incidence of liver failure, 
and lowered postoperative ileus, while decreasing overall cost [63, 66, 
71]. Moreover, it seems that patients with LLR had a faster oral intake 
and required less intravenous narcotic use [69]. LLR achieved similar 
short and long term oncologic outcomes for HCC or colorectal liver 
metastases (CLM) [62, 65, 72]. Finally, some authors advocated the 
systematic use of LLR for left lateral resection in benign liver lesions 
and in living donors for pediatric liver living donor transplantation [73, 
74].  
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Recommendation: LLR can be performed by hepato-biliary 
surgeons experienced in laparoscopic surgery, in particular left 
lateral sectionectomy and resections of lesions located in 
anterior segments.  
Evidence level: moderate 
Grade of recommendation: strong 
There were no studies assessing the safety of robotic liver 
surgery in patients within an ERAS protocol. Robotic liver resection 
seems to be feasible by hepato-biliary surgeons with advanced 
training, especially for lesions located in the postero-superior segments 
[75, 76]. However, according to a recent large series comparing robotic 
versus laparoscopic hepatectomy, significant benefits were not 
demonstrated yet [77].  
Recommendation: There is currently no proven advantage of 
robotic liver resection in ERAS. Its use should be reserved for 
clinical trials. 
Evidence level: low 
Grade of recommendation: weak 
 
12.  Prophylactic Nasogastric intubation 
 Two recent Cochrane systematic reviews demonstrated that 
prophylactic nasogastric intubation after abdominal surgery should be 
abandoned in favor of selective use. Increased pulmonary 
complications and longer time to return of bowel function were 
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observed in patients with routine nasogastric tube [78]. One RCT 
(including 200 patients) confirmed those results after hepatectomy [79].  
 
Recommendation: Prophylactic nasogastric intubation 
increases the risk of pulmonary complications after 
hepatectomy. Its routine use is not indicated. 
Evidence level: high 
Grade of recommendation: strong 
 
13. Prophylactic abdominal drainage 
 
The strongest evidence to omit routine prophylactic drainage 
after major abdominal surgery arises from a meta-analysis published in 
2004 [80]. This meta-analysis however, included 3 RCTs on liver 
resection only, with low sample size [81, 82]. Kyoden et al. assessed 
the value of prophylactic drainage in a retrospective cohort study 
including 1269 consecutive elective liver resections [83]. Prophylactic 
drainage reduced the frequency of subphrenic abcess and biliary fistula 
or bilioma formation.  
 
Recommendation: The available evidence is non-conclusive 
and no recommendation can be given for the use of prophylactic 
drainage or against it after hepatectomy. 
Evidence level: low 
Grade of recommendation: weak 
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14.  Preventing intraoperative hypothermia 
Normothermia (>36o) during surgery is recommended to reduce 
postoperative cardiac and non-cardiac complications [84-89]. However, 
no study specific to liver surgery investigating this point could be found. 
According to one RCT and one recent meta-analysis, even mild 
hypothermia increased significantly the risk for blood loss and 
transfusion [85, 89]. One meta-analysis suggested that circulating 
water garments offer better temperature control than forced air 
warming systems [90]. 
 
Recommendation: Perioperative normothermia should be 
maintained during liver resection.  
Evidence level: moderate 
Grade of recommendation: strong 
 
15.  Postoperative nutrition and early oral intake  
Lassen et al. conducted a multicenter randomized trial with 427 
digestive surgery patients, who received either normal food from 
postoperative day 1 or a conservative regimen with nil by mouth and 
enteral tube feeding [91]. There was no difference in complications, 
reoperations or mortality, but resumption of bowel function was faster 
in the “early food” group. Sixty-six patients in this study had either liver 
resection or hepatico-jejunostomy, confirming safety and benefits of 
early oral intake. Hendry et al. demonstrated the benefits of the routine 
use of oral laxatives combined with oral nutritional supplements in liver 
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surgery patients within enhanced recovery pathway [92]. Postoperative 
supplemental nutrition is only indicated in malnourished patients or in 
prolonged postoperative fasting (>5 days) such as when severe 
complications arise [25-27]. A systematic review confirmed that enteral 
nutrition should be preferred over parenteral nutrition after liver 
resections for better immune function and lower rates of infectious 
complications [93]. 
Recommendation: Most patients can eat normal food at day 
one after liver surgery. Postoperative enteral or parenteral 
feeding should be reserved for malnourished patients or those 
with prolonged fasting due to complications (e.g. ileus >5 days, 
delayed gastric emptying). 
Evidence level: Early oral intake: moderate; Oral nutritional 
supplements: moderate; No routine postoperative artificial 
nutrition: high. 
Grade of recommendation: Early oral intake: strong; Oral 
nutritional supplements: weak; No routine postoperative artificial 
nutrition: strong. 
 
16.  Postoperative glycaemic control 
Perioperative hyperglycemia is frequently observed after major 
surgery [94, 95]. These changes result from a transient insulin 
resistance with a compromised peripheral insulin-dependent glucose 
uptake [96]. Hyperglycemia induced by surgical stress results in 
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deregulation of liver metabolism and immune function, impairing 
postoperative recovery. In colorectal and pancreatic surgery, early 
postoperative hyperglycemia was associated with adverse outcomes 
[19, 97, 98]. Postoperative insulin sensitivity is significantly reduced in 
patients not treated with insulin during surgery [99]. In addition, there is 
a rapid change in glucose concentration during hepatectomy with 
Pringle maneuver, reflecting glycogen breakdown within hepatocytes 
because of hypoxia [100]. According to one RCT (n=88) patients who 
received insulin therapy using a closed-loop glycemic control system 
(i.e. an artificial pancreas) during hepatectomy had reduced total 
hospital costs and SSI [101]. There is evidence that preoperative oral 
supplementation with carbohydrate and branched-chain amino acid-
enriched nutrient decreased insulin resistance in patients undergoing 
hepatectomy [102]. A raised blood lactate after liver surgery, which 
correlates with postoperative morbidity [103], can be related to insulin 
resistance or to a mix between insulin resistance and ischemia-
reperfusion injury. Therefore insulin therapy should be initiated early. 
 
Recommendation: Insulin therapy to maintain normoglycaemia 
is recommended.  
Evidence level: moderate 
Grade of recommendation: strong 
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17.  Prevention of delayed gastric emptying 
Left-sided liver resection may be associated with a higher risk of 
DGE due to disruption of normal gastrointestinal movement at the point 
of contact between the stomach and the cut liver surface. According to 
2 RCTs, the use of omentum flap to cover the liver cut surface after 
left-sided hepatectomy reduced the incidence of DGE [104, 105].  
Recommendation: An omentum flap to cover the cut surface of 
the liver reduces the risk of DGE after left-sided hepatectomy. 
Evidence level: high  
Grade of recommendation: strong 
18. Stimulation of bowel movement 
According to 2 recent meta-analyses, the use of ERAS protocol 
significantly shortened the time to first flatus, hence reducing the 
postoperative ileus period [12, 106]. In the study by Hendry et al., the 
routine use of postoperative laxatives resulted in an earlier first 
passage of stool but the overall rate of recovery was unaltered in liver 
surgery patients [92]. The use of chewing gum (CG) after surgery has 
been addressed in a large Cochrane review [107]. This meta-analysis 
showed no clear benefit of CG in ERAS patients and included few 
patients with liver surgery. The use of laparoscopic surgery and aiming 
for a neutral fluid balance by avoiding salt and fluid overload in the 
postoperative period have been shown to reduce the risk of 
postoperative ileus [12, 66]. 
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Recommendation: Stimulation of bowel movement after liver 
surgery is not indicated. 
Evidence level: high 
Grade of recommendation: strong 
 
19. Early mobilization 
Bed rest is associated with multiple documented deleterious 
effects [108, 109]. Bed rest favors diffuse muscle atrophy, 
thromboembolic disease, and insulin resistance [110]. There was no 
evidence that early mobilization is deleterious after liver surgery. 
Further studies are needed to determine the frequency and the number 
of hours required to improved patients outcome. 
Recommendation: Early mobilization after hepatectomy should 
be encouraged from the morning after the operation until 
hospital discharge.  
Evidence level: low 
Grade of recommendation: weak 
 
20.  Analgesia  
 
In one RCT using Thoracic Epidural Analgesia (TEA) a short length 
of stays of 4 days after major liver resection was achieved with low 
complication rate [13]. A concern using TEA is the possible 
prolongation of prothrombin time after hepatectomy, which may delays 
epidural catheter removal and increases administration of corrective 
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blood products [111]. A recent RCT showed that epidural analgesia in 
open liver resection might be a risk factor for postoperative kidney 
failure due to hypotension [112]. Several studies have suggested that 
intrathecal opiates are a suitable alternative to epidural analgesia and 
traditional morphine PCA [113, 114]. One recent RCT compared the 
role of local anesthetic wound infusion catheter plus patient-controlled 
opiate analgesia to standard epidural analgesia after open liver 
resection within an ERAS protocol [115]. Wound infusion reduced the 
length of time required to fulfill criteria for hospital discharge, however 
epidural analgesia conferred better analgesia control. A meta-analysis 
of 4 studies (n=705) with open liver resections has shown lower pain 
scores on day 1 post operatively with epidural, but similar outcome 
compared to local anesthetic infiltration via wound catheters [116]. 
There was no difference in hospital length of stay and the overall 
complication rate was higher in the epidural group.  
 
 
Recommendations: Routine TEA cannot be recommended in 
open liver surgery for ERAS patients. Wound infusion catheter 
or intrathecal opiates can be good alternatives when combined 
with multimodal analgesia.  
Evidence level: moderate 
Grade of recommendation: strong 
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21. Postoperative nausea and vomiting 
Postoperative nausea and vomiting (PONV) is common after 
major surgery, but the multimodal approach within ERAS pathway 
enables most patients after liver resection to eat on postoperative day 
1 [13]. Risk factors are assessed preoperatively and include: previous 
PONV, female gender, younger age, non-smoker, and use of volatile 
anesthetic agents and opioids [117]. 5HT3 antagonists remain the first 
line therapy due to their good side effect profile. Low dose 
dexamethasone improves liver regeneration (with no additional benefit 
at higher doses) [118]. As dexamethasone can worsen glycemic 
control, it should be used with caution in diabetics. Other secondary 
drugs are antihistamines, butyrophenones and phenothiazines [118].  
 
Recommendations: A multimodal approach to PONV should 
be used. Patients should receive PONV prophylaxis with 2 
antiemetic drugs.  
Evidence level: moderate 
Recommendation Grade: strong   
 
 22. Fluid management 
The reduction of hepatic venous congestion by careful control of 
central venous pressure (CVP) during hepatic resection is associated 
with a reduction in intraoperative blood loss [119-121]. A Cochrane 
review evidenced that a lower CVP reduced blood loss, but there was 
no difference in red cell transfusion requirements, intraoperative 
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morbidity or long-term survival benefits [122]. Those results were 
confirmed in a recent meta-analysis by Hughes et al. [123]. Although 
the measure of stroke volume variation (SVV) has been proposed as 
appropriate replacement for CVP monitoring [124], it is more likely that 
a synergistic combination of CVP monitoring and SVV methods will 
become the standard form of hemodynamic monitoring in liver surgery.  
One recent study has demonstrated that goal directed fluid 
therapy at the end of hepatic resection and during the first 6 hours 
enabled a faster restoration of circulating volume with reduction of 
complications [13]. The use of balanced crystalloid solution rather than 
0.9% normal saline to maintain intravascular volume is recommended 
to avoid hyperchloremic acidosis and other causes of postoperative 
morbidity [125, 126]. The role of colloids remains controversial and the 
use of hetastarches increases the risk of renal dysfunction when a 
SIRS response and sepsis is presents, and should be avoided in liver 
resection [127].  
Recommendations: The maintenance of low CVP (below 5 
cmH2O) with close monitoring during hepatic surgery is 
advocated. Balanced crystalloid should be preferred over 0.9% 
saline or colloids to maintain intravascular volume and avoid 
hyperchloraemic acidosis or renal dysfunction, respectively. 
Evidence level: moderate 
Recommendation Grade:  strong  
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21.  Audit 
 
The effectiveness of audit in improving healthcare has been 
demonstrated in a recent Cochrane systematic review [128]. Feedback 
was more efficient when baseline performance was low, when the 
source was a supervisor or a colleague, and when it was provided 
more than once, delivered in verbal and written formats, and when it 
included both explicit targets and action plan. Since strict adherence to 
the protocol is paramount for the success of ERAS implementation, 
auditing compliance has become per se a key element [34].  
Recommendation: Systematic audit improves compliance and 
clinical outcome in healthcare practice 
Evidence level: moderate 
Grade of recommendation: strong 
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Conclusions 
This systematic review highlights that the current available data 
on enhanced recovery pathways in liver surgery is scarce and lacks 
standardization. Although 16 out of the 23 standard items of ERAS 
were studied for liver surgery, the quality and level of evidence of the 
studies remain low. The highest level of evidence (level 1 or 2) was 
available for only 5 items. Though the value of enhanced recovery 
pathways has now been demonstrated in colorectal surgery, with a 
significant reduction in morbidity, cost and hospital stay, there is a need 
to perform high quality studies to confirm the benefit of ERAS pathways 
in liver surgery. In conclusion, the proposed ERAS pathway for liver 
surgery is based on the best available evidence, but it needs to be 
further investigated. In addition, a very important aspect of ERAS 
pathways is the assessment of adherence to the protocol (compliance). 
Compliance with the new proposed liver ERAS protocol should be 
documented as part of further trial to allow benchmarking. 
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Figures Legend 
 
Figure 1. PRISMA Flow diagram 
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Table 1. Summary of ERAS recommendations for each item and the 
respective level of evidence  
ERAS items Summary Evidence 
level 
Grade of 
recommendation 
1. Preoperative 
counselling 
Patients should receive 
routine dedicated 
preoperative counseling 
and education before liver 
surgery. 
Moderate Strong 
2. Perioperative 
nutrition 
Patients at risk (weight 
loss >10-15% within 6 
months, BMI<18.5 kg/m2, 
and serum albumin<30 g/l 
in the absence of liver or 
renal dysfunction) should 
receive oral nutritional 
supplements for seven 
days prior to surgery. For 
severely malnourished 
patients (>10% WL), 
surgery should be 
postponed for at least 2 
weeks to improve 
nutritional status and 
allow patients to gain 
weight. 
High Strong 
3. Perioperative oral 
immunonutrition 
There is limited evidence 
for the use of IN in liver 
surgery. 
Low Weak 
4. Preoperative fasting 
and preoperative 
carbohydrates load 
Preoperative fasting does 
not need to exceed 6 
hours for solids and 2 
hours for liquids. 
Carbohydrate loading is 
recommended the 
evening before liver 
surgery and 2 hours 
before induction of 
anesthesia. 
No 
preoperative 
fasting more 
than 6 hours: 
moderate  
Carbohydrate 
loading: low 
No preoperative 
fasting more than 6 
hours: strong 
 
Carbohydrate 
loading: weak 
5. Oral bowel 
preparation 
Oral MBP is not indicated 
before liver surgery. 
Low Weak 
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6. Pre-anesthetic 
medication 
Long acting anxiolytic 
drugs should be avoided. 
Short acting anxiolytics 
may be used to perform 
regional analgesia prior to 
the induction of 
anesthesia. 
Moderate Strong 
7. Anti-thrombotic 
prophylaxis 
  
LMWH or unfragmented 
heparin reduces the risk 
of thromboembolic 
complications and should 
be started 2-12 hours 
before surgery, 
particularly in major 
hepatectomy. Intermittent 
pneumatic compression 
stockings should be 
added to further decrease 
this risk. 
Use of 
heparin: 
moderate 
Use of 
intermittent 
pneumatic 
compression 
devices: low 
Use of heparin: 
strong 
                            
Use of intermittent 
pneumatic 
compression 
devices: weak 
8. Peri-operative 
steroids 
administration 
Steroids 
(methylprednisolone) may 
be used before 
hepatectomy in normal 
liver parenchyma, since it 
decreases liver injury and 
intraoperative stress, 
without increasing the risk 
of complications. Steroids 
should not be given in 
diabetic patients. 
moderate weak 
9. Antimicrobial 
prophylaxis and skin 
preparation 
Single dose Intravenous 
antibiotics should be 
administered before skin 
incision and less than one 
hour before hepatectomy. 
Postoperative 
“prophylactic” antibiotics 
are not recommended. 
Skin preparation with 
chlorhexidine 2% is 
superior to povidone-
iodine solution. 
Antimicrobial 
prophylaxis: 
moderate  
                   
 
 
Skin 
preparation: 
moderate 
Antimicrobial 
prophylaxis: strong  
 
 
 
                          
Skin preparation: 
strong 
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10. Incision The choice of incision is at 
the surgeon’s discretion. It 
depends on the patient’s 
abdominal shape and 
location in the liver of the 
lesion to be resected. 
Mercedes-type incision 
should be avoided due to 
higher incisional hernia 
risk. 
Moderate Strong 
11. Minimally invasive 
approach 
LLR can be performed by 
hepato-biliary surgeons 
experienced in 
laparoscopic surgery, in 
particular left lateral 
sectionectomy and 
resections of lesions 
located in anterior 
segments.  
There is currently no 
proven advantage of 
robotic liver resection in 
ERAS. Its use should be 
reserved for clinical trials. 
Minimally 
invasive 
approach: 
moderate 
 
 
 
Robotic 
surgery: low 
Minimally invasive 
approach: strong 
 
 
 
 
Robotic surgery: 
weak 
12. Prophylactic 
Nasogastric 
intubation 
Prophylactic nasogastric 
intubation increases the 
risk of pulmonary 
complications after 
hepatectomy. Its routine 
use is not indicated. 
High Strong 
13. Prophylactic 
abdominal drainage 
The available evidence is 
non-conclusive and no 
recommendation can be 
given for the use of 
prophylactic drainage or 
against it after 
hepatectomy. 
Low Weak 
14. Preventing 
intraoperative 
hypothermia 
Perioperative 
normothermia should be 
maintained during liver 
resection. 
Moderate Strong 
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15. Postoperative 
nutrition and early 
oral intake 
Most patients can eat 
normal food at day one 
after liver surgery. 
Postoperative enteral or 
parenteral feeding should 
be reserved for 
malnourished patients or 
those with prolonged 
fasting due to 
complications (e.g. ileus 
>5 days, delayed gastric 
emptying). 
Early oral 
intake: 
moderate  
Oral nutritional 
supplements: 
moderate  
No routine 
postoperative 
artificial 
nutrition: high 
Early oral intake: 
strong 
                          
Oral nutritional 
supplements: weak  
                             
No routine 
postoperative 
artificial nutrition: 
strong 
16. Postoperative 
glycaemic control 
Insulin therapy to maintain 
normoglycaemia is 
recommended. 
Moderate Strong 
17. Prevention of 
delayed gastric 
emptying (DGE) 
An omentum flap to cover 
the cut surface of the liver 
reduces the risk of DGE 
after left-sided 
hepatectomy. 
High Strong 
18. Stimulation of 
bowel movement 
Stimulation of bowel 
movement after liver 
surgery is not indicated. 
High Strong 
19. Early mobilization Early mobilization after 
hepatectomy should be 
encouraged from the 
morning after the 
operation until hospital 
discharge. 
Low Weak 
20. Analgesia Routine TEA cannot be 
recommended in open 
liver surgery for ERAS 
patients. Wound infusion 
catheter or intrathecal 
opiates can be good 
alternatives combined 
with multimodal analgesia. 
Moderate Strong 
21. Preventing 
postoperative nausea 
and vomiting (PONV) 
Multimodal approach to 
PONV should be used. 
Patients should receive 
PONV prophylaxis with 2 
antiemetic drugs. 
Moderate Strong 
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22. Fluid management The maintenance of low 
CVP (below 5 cmH2O) 
with close monitoring 
during hepatic surgery is 
advocated. Balanced 
crystalloid should be 
preferred over 0.9% saline 
or colloids to maintain 
intravascular volume and 
avoid hyperchloraemic 
acidosis or renal 
dysfunction, respectively. 
Moderate Strong 
23. Audit 
 
 
Systematic audit improves 
compliance and clinical 
outcome in healthcare 
practice 
Moderate Strong 
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Author Year Jadad                score 
Level 
evidence 
Studied           
items Morbidity LOS 
Lassen 2008 6 1 Postoperative artificial nutrition No difference No difference 
Darouiche 2010 4 1 Skin preparation 
Preoperative cleansing 
with chlorhexidine is 
superior to povidone 
iodine for preventing SSI 
Not 
asssessed 
Hayashi 2011 7 1 
Peri-operative 
steroids 
administration 
Positive impact on liver 
function. No difference in 
complications 
No difference 
Wong 2007 5 2 
Preventing 
intraoperative 
hypothermia 
Perioperative warming 
reduce blood loss and 
complications 
No difference 
Okabayashi 2009 3 2 Postoperative glycaemic control 
Intensive insulin therapy 
using a closed loop 
system lower SSI 
Decreased 
Pessaux 2007 5 2 
Prophylactic 
Nasogastric 
intubation (NGT) 
NGT has no advantage. 
NGT increased the risk 
of pulmonary 
complications 
No difference 
Igami 2011 4 2 
Prevention of 
delayed gastric 
emptying (DGE) 
DGE reduced with 
omental flap on the cut 
surface after left sided 
hepatectomy 
Not assessed 
Yoshida 2005 3 2 
Prevention of 
delayed gastric 
emptying (DGE) 
DGE reduced with 
omental flap on the cut 
surface after left sided 
hepatectomy 
Not assessed 
Hendry 2010 2 2 
Use of 
postoperative 
laxatives 
Earlier passage of first 
stool, no change in 
morbidity 
Decreased 
Jones 2013 7 1 Goal directed fluid therapy Decreased Decreased 
 
  
Table 2. RCTs dedicated to liver surgery selected in the systematic review with the level of evidence 
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Table 3.  Items with <75% expert agreement in rounds 1 and 2 of the Delphi process 
 
 
 
Item Round of disagreement % of agreement 
Perioperative oral 
immunonutrition 1 42 
Perioperative steroids 
administration 1/2 42/71 
Epidural analgesia 1 42 
Minimally invasive 
surgery 1 71 
Robotic surgery 1 57 
Fluid management 1/2 29/71 
Prophylactic 
abdominal drainage 1 71 
 
 
 
